Department of Pathology, Stanford Medical School Blood Center, 3373 Hillview Ave, Palo Alto, CA 94304, USA.
Blood. 2013 May 30;121(22):4603-10. doi: 10.1182/blood-2013-02-481945. Epub 2013 Apr 17.
A single mismatch in highly expressed HLA-A, -B, -C, and -DRB1 loci (HEL) is associated with worse outcomes in hematopoietic stem cell transplantation, while less is known about the cumulative impact of mismatches in the lesser expressed HLA loci DRB3/4/5, DQ, and DP (LEL). We studied whether accumulation of LEL mismatches is associated with deleterious effects in 3853 unrelated donor transplants stratified according to number of matches in the HEL. In the 8/8 matched HEL group, LEL mismatches were not associated with any adverse outcome. Mismatches at HLA-DRB1 were associated with occurrence of multiple LEL mismatches. In the 7/8 HEL group, patients with 3 or more LEL mismatches scored in the graft-versus-host vector had a significantly higher risk of mortality (1.45 and 1.43) and transplant-related mortality (1.68 and 1.54) than the subgroups with 0 or 1 LEL mismatches. No single LEL locus had a more pronounced effect on clinical outcome. Three or more LEL mismatches are associated with lower survival after 7/8 HEL matched transplantation. Prospective evaluation of matching for HLA-DRB3/4/5, -DQ, and -DP loci is warranted to reduce posttransplant risks in donor-recipient pairs matched for 7/8 HEL.
在高度表达的 HLA-A、-B、-C 和 -DRB1 基因座(HEL)中出现单个错配与造血干细胞移植的不良结局相关,而在表达较少的 HLA-DRB3/4/5、DQ 和 DP 基因座(LEL)中错配的累积影响知之甚少。我们研究了在根据 HEL 匹配数分层的 3853 例无关供体移植中,LEL 错配是否与有害影响相关。在 8/8 匹配的 HEL 组中,LEL 错配与任何不良结局均无关。HLA-DRB1 错配与多个 LEL 错配的发生相关。在 7/8 HEL 组中,具有 3 个或更多 LEL 错配的患者在移植物抗宿主病向量中得分显著更高的死亡率(1.45 和 1.43)和移植相关死亡率(1.68 和 1.54)比具有 0 或 1 个 LEL 错配的亚组。没有单个 LEL 基因座对临床结局有更显著的影响。在 7/8 HEL 匹配移植后,具有 3 个或更多 LEL 错配与较低的存活率相关。需要前瞻性评估 HLA-DRB3/4/5、-DQ 和 -DP 基因座的匹配,以降低 7/8 HEL 匹配供体-受者配对移植后的移植后风险。